These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2481162)

  • 21. [Changes in cerebral and central hemodynamics in response to hypotensive therapy of patients with essential hypertension and different types of circulation].
    Sidorenko GI; Pavolova AI; Gaĭduk VN; Al'khimovich VM; Nechesova TA
    Ter Arkh; 1986; 58(11):18-21. PubMed ID: 2881362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical consequences of the autonomic imbalance in hypertension and congestive heart failure.
    Julius S; Nesbitt S
    Scand Cardiovasc J Suppl; 1998; 47():23-30. PubMed ID: 9540130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of antihypertensive therapy on blood pressure reactivity during mental stress.
    Rüddel H; Schmieder R; Langewitz W; Schulte W
    J Hum Hypertens; 1988 Mar; 1(4):259-65. PubMed ID: 3221374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five decades of antihypertensive treatment: the unresolved issues.
    Julius S
    J Hypertens Suppl; 2000 Jul; 18(3):S3-7. PubMed ID: 10952081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood pressure, diabetes and diabetic nephropathy.
    Chantrel F; Moulin B; Hannedouche T
    Diabetes Metab; 2000 Jul; 26 Suppl 4():37-44. PubMed ID: 10922972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moxonidine: a new antiadrenergic antihypertensive agent.
    Prichard BN; Graham BR; Owens CW
    J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new approach to the identification of pathogenetic factors and to therapy in human primary hypertension.
    Korner PI; Jennings GL; Esler MD; Broughton A
    J Clin Hypertens; 1987 Jun; 3(2):187-96. PubMed ID: 2956375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
    Ibrahim MM; el-Boghdadly B; Zaghloul SS
    J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular hypertrophy and hypertension: causes and consequences.
    Korner PI
    Blood Press Suppl; 1995; 2():6-16. PubMed ID: 7582077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity-associated hypertension: hypothesized link between etiology and selection of therapy.
    Reisin E; Tuck ML
    Blood Press Monit; 1999; 4 Suppl 1():S23-6. PubMed ID: 10822414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sympathetic nervous factors, pressure variability and organ damage in arterial hypertension].
    Mancia G; Seravalle G; Grassi G
    Ann Ital Med Int; 1997; 12(4):217-22. PubMed ID: 9773576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic measurements as aids to choosing drug treatment of essential hypertension.
    Chen HC
    Clin Ther; 1985; 7(2):176-80. PubMed ID: 3986862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of antihypertensive therapy on sympathetic nervous system activity in patients with essential hypertension.
    Chernow B; Zaloga GP; Lake CR; Coleman MD; Ziegler MG
    Fed Proc; 1984 Jan; 43(1):72-7. PubMed ID: 6317467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of hypertension and ischemic heart disease.
    Mancia G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S12-9. PubMed ID: 2483226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of antihypertensive treatment on small artery remodelling.
    Agabiti-Rosei E; Heagerty AM; Rizzoni D
    J Hypertens; 2009 Jun; 27(6):1107-14. PubMed ID: 19293726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antihypertensive treatment and left ventricular hypertrophy].
    Agabiti-Rosei E; Muiesan ML; Rizzoni D
    Ann Ital Med Int; 1993 Oct; 8 Suppl():97S-103S. PubMed ID: 8117529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Structural factor" in primary and secondary hypertension.
    Folkow B
    Hypertension; 1990 Jul; 16(1):89-101. PubMed ID: 2365448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural factors: the vascular wall. Consequences of treatment.
    Folkow B
    Hypertension; 1983; 5(5 Pt 2):III58-62. PubMed ID: 6629463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.